The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nanotechnology licence agreement

3 Jun 2019 07:00

RNS Number : 8270A
TP Group PLC
03 June 2019
 

RNS Reach

3 June 2019

 

TP Group plc

("TP Group" or the "Company" or the "Group")

 

Nanotechnology licence for carbon dioxide treatment

TP Group (AIM: TPG), the specialist services and engineering group, has entered into a nine year exclusive licensing agreement with Batelle Inc., to be a technology partner for their innovative nanotechnology material, SAMMS (the "Agreement"). The Agreement enables TP Group to develop and deploy carbon dioxide (CO2) removal equipment for transportation and life support systems in ground, marine, air and space vehicles.

Batelle Inc. is a global research and development organisation, headquartered in Columbus, Ohio in the United States. Their facility at Pacific Northwest National Laboratory has produced a new nanostructured sorbent material. SAMMS was originally developed under funding from the US Department of Energy to bind mercury from contaminated groundwater. It has many other applications including the treatment of carbon dioxide.

It is intended that the SAMMS material will be used as the basis for an alternative approach to management of carbon dioxide levels in confined spaces. The new systems are designed to offer a technological and performance boost in this application as the sand-like material differs from existing treatments in either solid or liquid form and eliminates certain of their environmental and operational issues.

TP Group will continue to work with the traditional systems that it has supplied to many global customers, with the new systems sitting alongside these to provide a more comprehensive range of options in this field.

Phil Cartmell, Chief Executive Officer of TP Group, commented:

"This Agreement demonstrates our continued and successful investment in technology development and adoption to deliver the most advanced solutions to our customers whilst also allowing them to select from a range of options to find the one that best suits their long-term operational needs.

"It is part of TP Group's strategy to develop a Centre of Excellence for gas and fluid management systems - specifically arising from our historical strength in CO2 capture. This Agreement complements our partnership with Micropore Inc. and contributes to the Group's plan to be a trusted provider of a range of compact, high-performance equipment with many applications in the defence, space and global energy sectors."

 

For further information, please contact:

 

TP Group plc

Tel: 01753 285 810

Phil Cartmell, Chief Executive Officer

Derren Stroud, Chief Financial Officer

www.tpgroup.uk.com

Cenkos Securities plc

Tel: 020 7397 8980

Mark Connelly / Stephen Keys / Callum Davidson

www.cenkos.com

Vigo Communications

Tel: 020 7390 0230

Jeremy Garcia / Fiona Henson / Charlie Neish

www.vigocomms.com

 

 

Notes to Editors

 

TP Group designs and develops advanced technologies, engineers complex equipment and systems, and provides support throughout their operational life. The Company's shares have been traded on AIM since July 2001.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRALLFEEEDILVIA
Date   Source Headline
5th Apr 201212:33 pmRNSHolding(s) in Company
5th Apr 201212:31 pmRNSHolding(s) in Company
30th Mar 201211:04 amRNSResult of EGM
15th Mar 20127:00 amRNSAcquisition and Placing
12th Mar 20127:00 amRNSTechnology Update
13th Jan 20129:34 amRNSHolding(s) in Company
4th Jan 20127:00 amRNSNew Technology Centre and Website
28th Nov 20119:47 amRNSHolding(s) in Company
22nd Nov 201111:49 amRNSHolding(s) in Company
17th Oct 20117:00 amRNSDirectorate Change
10th Oct 20113:53 pmRNSHolding(s) in Company
10th Oct 20113:46 pmRNSHolding(s) in Company
4th Oct 20117:00 amRNSBusiness Update
11th Aug 20117:00 amRNSInterim Results
11th Jul 20117:00 amRNSNotice of Results
28th Jun 20112:26 pmRNSHolding(s) in Company
6th Jun 20117:00 amRNSAppointment of Managing Director
19th May 201112:20 pmRNSAGM Update
19th May 201111:23 amRNSBusiness Update
17th May 20117:00 amRNSTechnology Partnership signed with Saudi Aramco
18th Apr 20117:00 amRNSDirector/PDMR Shareholding
4th Apr 201110:32 amRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSDirector/PDMR Shareholding
29th Mar 20117:00 amRNSPreliminary Results
28th Mar 20117:00 amRNSMoU signed with new global industrial partner
28th Feb 20117:00 amRNSEuropean DGC Feasibility Study
10th Feb 20119:54 amRNSNorth America DGC Development Project Update
8th Feb 20117:00 amRNSAppointment of Non Executive Director
1st Feb 20117:00 amRNSPre-close Trading Statement
12th Jan 20117:00 amRNSDGC Update
17th Dec 201011:58 amRNSENI DGC Update
13th Dec 20104:53 pmRNSHolding(s) in Company
13th Dec 20103:03 pmRNSHolding(s) in Company
13th Dec 20103:00 pmRNSHolding(s) in Company
13th Dec 20102:56 pmRNSHolding(s) in Company
13th Dec 201011:39 amRNSHolding(s) in Company
7th Dec 201010:47 amRNSDirector/PDMR Shareholding
6th Dec 201012:41 pmRNSResults of General Meeting
25th Nov 20109:22 amRNSOperational Update
12th Nov 20105:12 pmRNSNotice of posting of prospectus
12th Nov 20107:00 amRNSPlacing and Open Offer
5th Nov 20102:45 pmRNSPress Speculation
25th Aug 20107:00 amRNSNew Development Agreement
12th Aug 20107:00 amRNSInterim Results
6th Aug 20107:00 amRNSNotification of Results and Change of Advisor
5th Jul 20107:00 amRNSAppointment of Chairman
30th Jun 20108:16 amRNSAnnual Financial Report
24th Jun 20101:12 pmRNSAGM Statement
4th May 20107:00 amRNSDirectors' Dealings
29th Apr 201011:19 amRNSDirectors Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.